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These GPI–protein interactions are crucial to initiate different 
signaling events within these subdomains (Paulick and Bertozzi, 
2008). Other lipid modifications, such as palmitoylation, have been 
characterized in proteins which have an important role in neuronal 
maintenance, such as Src tyrosine kinases (SKTs; Sato et al., 2009) 
and steroid receptors (Pedram et al., 2007).
Apart from lipidic anchors, raft scaffolding proteins, such as 
caveolin family, may importantly contribute to the stable inser-
tion of signaling proteins into neuronal lipid rafts (Parton, 2003). 
These proteins not only provide stabilizing scaffolds for lipid raft 
maintenance, but also serve to compartmentalize specific signaling 
molecules within these domains, with the prospect of rapidly and 
selectively modulating cell signaling events (Lajoie et al., 2009). 
Thus, caveolins have been shown to regulate a variety of key signaling 
elements, including G-proteins, and STK,  phosphatidylinositol-3 
kinase (PI3K) and mitogen-activated protein kinase (MAPK) 
pathways (Arcaro et al., 2007). Moreover, caveolins interact with 
the amyloid precursor protein (APP) modulating amyloidogenic 
processing (Ehehalt et al., 2003), and with membrane estrogen 
receptors (mERs; Boulware et al., 2007; Marin et al., 2008), thus 
modifying neuroprotective responses.
Lipid rafts are also platforms for neurotrophic signaling initiated 
by diverse neurotrophins which are essential for synaptic transmis-
sion, axon guidance, and cell adhesion (Tsui-Pierchala et al., 2002). 
In this sense, different neurotrophin and neurotransmitter recep-
tors are located in these microstructures, and channel activity and 
properties appear to vary depending upon their location in rafts 
(Martens et al., 2000).
Signaling platformS in neuronal lipid raftS
Neuronal signal transduction is initiated at the plasma membrane 
by a plethora of protein and lipid interactions which are crucial 
for the correct cellular communication and activities, and whose 
alterations may determine cognitive and neurological impairments. 
An accepted fact is that cognitive decline that occurs with normal 
aging, and is exacerbated in certain neuropathologies, is mainly 
related to functional changes in intracellular signaling cascades and 
cellular communication that alter normal neuronal responses. In 
these order of ideas, liquid-ordered microdomains of the plasma 
membrane, or lipid rafts, are a preferential location of many signal-
ing proteins. These membrane subdomains are presently defined as 
dynamic assemblies of proteins and specific lipid classes, i.e., cho-
lesterol, sphingolipids, gangliosides, in which different lipid–lipid, 
lipid–protein, and protein–protein oligomerizing interactions take 
place, thus stimulating raft stability (Simons and Gerl, 2010). In 
lipid rafts, molecules can move and interact with different kinetics 
in response to a variety of intra- and/or extracellular ligands that 
may ultimately favor specific protein interactions and signaling 
cascades activation. Therefore, the distribution of lipid hallmarks 
in these microstructures that modulate membrane fluidity and 
other physicochemical properties may affect protein dynamics, and 
presumably alter their function and signal transduction.
In this sense, many raft intrinsic proteins contain a lipid moiety 
contributing to their stabilization and functioning. For example, 
numerous proteins have a special post-translational modification 
known as the glycosylphosphatidylinositol (GPI) anchor, which 
serves to attach the proteins to the cell membrane and lipid rafts. 
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Thus, lipid rafts within neuronal membranes can integrate 
 protein signaling platforms or “signalosomes,” which may be are 
crucial for the development of neuronal physiological activities.
SignaloSomeS involved in neuronal preServation: 
the paradigm of er–vdaC–Caveolin-1 Complex 
related to ad
It is widely accepted that estrogen develops some crucial actions in 
the regulation of brain development, plasticity, and preservation 
(Suzuki et al., 2006). Thus, estrogen signaling mechanisms have 
been demonstrated in neurogenesis, neuronal differentiation, syn-
aptic plasticity, and neuroprotection, mainly in brain areas involved 
in mood and cognitive processes (Marin et al., 2005; Raz et al., 
2008). These actions can be exerted through hormone binding to 
different cell surface targets, including mERs that activate rapid 
mechanisms of action (Vasudeban and Pfaff, 2008). Indeed, mER 
participates in neuroprotection against amyloid-beta (Aβ)-induced 
neurotoxicity (Marin et al., 2003), through the rapid estrogen acti-
vation of MAPK signaling pathway (Guerra et al., 2004). Aβ aggre-
gation is a main hallmark of Alzheimer’s disease (AD) pathology, 
and is derived from the proteolysis of APP within lipid rafts (Vardy 
et al., 2005). Other data in different cell and animal models have 
corroborated the involvement of rapid mER actions in preventing 
Aβ-induced degeneration (Pike et al., 2009).
A recent interesting finding is that mER is highly enriched in 
neuronal lipid rafts of different cognitive areas in human brains. 
This molecule, lacking large hydrophobic domains, is stabilized 
by interactions with caveolin-1 and other proteins, including plas-
malemmal voltage-dependent anion channel (pl-VDAC) and the 
insulin growth factor-1 receptor (IGF-1R; Ramirez et al., 2009). 
These proteins integrated in a macromolecular complex may 
form a signaling platform involved in different neuroprotective 
activities against a variety of injuries (Marin et al., 2009). Indeed, 
present available evidences have demonstrated that estrogen 
receptor (ER) and IGF-1R pathways cross-talk with each other 
to promote neuroprotective events, and this association appears 
to be affected with aging (Garcia-Segura et al., 2007). Moreover, 
this macromolecular complex may be differentially activated by 
the natural ligands of these receptors, i.e., estrogens and IGF-1, 
thereby adapting the neuronal response to extracellular ligand 
availability that may modulate the intracellular signaling machin-
ery (Marin et al., 2009). In support of this hypothesis, some data 
has evidenced that pl-VDAC activation and gating may be reg-
ulated by rapid actions of estrogens through phosphorylation 
processes (Diaz et al., 2001), and this may importantly contrib-
ute to neuronal survival against AD neurotoxicity. As observed 
in immunochemical studies, voltage-dependent anion channel 
(VDAC) is highly enriched in cortical lipid rafts of AD brains, 
and is abundant surrounding senile plaques in either AD mouse 
or human brains (Ferrer, 2009; Ramirez et al., 2009), suggesting 
a role for this porin in AD development. Furthermore, in cul-
tured neurons, pl-VDAC has been shown to be involved in the 
mechanisms of Aβ-induced toxicity, observing a reduction of 
amyloid neurotoxicity following a physical closing of the channel 
(Marin et al., 2007). It has also been suggested that VDAC may 
interact with Aβ, thereby promoting its aggregation and contrib-
uting to neurotoxicity (Thinnes, 2010). Therefore, the regulation 
of pl-VDAC gating in this  signalosome to maintain the channel 
inactivated may be crucial for neuronal preservation against Aβ 
neurotoxicity. In this order of ideas, it has been demonstrated that 
estradiol triggers a PKA/Src kinase pathway to rapidly promote 
VDAC phosphorylation in neuronal membranes (Herrera et al., 
2011a), a phenomenon that may increase estrogen cell survival 
against Aβ neurotoxicity (Herrera et al., 2011b). Altogether, these 
data suggest that ER/VDAC association in lipid rafts plays a pivotal 
role in preservation against AD.
An emerging concept is that potential disruption of these 
signalosomes as a consequence of different factors affecting the 
homeostasis of lipid rafts may underpin the etiology of different 
neuropathologies. In this order of ideas, the molecular complex 
formed by ER, VDAC, and caveolin-1 appears to be disrupted in 
lipid rafts at late stages of AD. Thus, in lipid rafts from cortical areas 
of AD brains, VDAC maintains, and even enhances, its association 
with caveolin-1 whereas ER is mainly enriched in astrocytes, in 
particular, surrounding amyloid plaques (Ramirez et al., 2009). 
The up-regulation of ER in astrocytes following an insult has been 
previously reported, suggesting a protective role of this receptor 
against inflammation (Lu et al., 2003). These protein rearrange-
ments occurring in lipid rafts of AD brains may profoundly affect 
signaling responses for neuronal integrity, a possibility that requires 
further exploration.
A sustainable possibility is that aberrant interactions in mul-
timolecular signaling complexes such as the one formed by ER, 
VDAC, IGF-1R, and caveolin-1 may be largely affected by altera-
tions of lipid composition in lipid rafts, a fact that modifies the 
physicochemical properties of these microstructures. In the last 
years, the hypothesis that raft changes in lipid composition may 
contribute to neuropathologies has gained considerable support 
(Rushworth and Hooper, 2011). Thus, structural modifications in 
lipid rafts induced by alterations in cholesterol, ganglioside, and 
polyunsaturated fatty acids (PUFA) content result in the develop-
ment of different aspects of AD pathology (Hashimoto et al., 2002; 
Martin et al., 2010). The biological relevance of raft-associated cho-
lesterol and gangliosides related to different neurological diseases 
has been recently reviewed (Schengrund, 2010).
These changes may compromise lipid raft structure provok-
ing lipid rearrangements which alter numerous properties of 
these structures, such as homeoviscous state, unsaturation index, 
peroxidability, and fluidity (Aksenov et al., 2001). Alterations in 
the physicochemical properties of lipid rafts may also affect struc-
ture–activity relationships of proteins involved in a broad range 
of neurodegenerative diseases, including, apart from AD, prion 
diseases, Huntington’s disease, amyotrophic lateral sclerosis, and 
Parkinson’s disease (Taylor and Hooper, 2007; Schengrund, 2010).
Additional support for this concept is starting to be provided 
by the observed integration in lipid rafts of proteins which are 
hallmarks of different pathogenesis, such as the prion protein 
(PrPc), alpha synuclein and parkin (Park et al., 2009; Pani et al., 
2010; Schengrund, 2010). Thus, PrPc is constitutively expressed 
in neurons as a GPI-anchored protein localized in lipid rafts, and 
these compartments play an important role in the propagation of 
prion disease (Russelakis-Caneiro et al., 2004; Morris et al., 2006). 
Moreover, alpha synuclein also interacts with these membrane com-
partments, and raft disruption relocates this protein away from 
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perSpeCtiveS
An increasing number of reports indicate that compartmentaliza-
tion of signaling macrocomplexes in lipid rafts have a pivotal role 
in the regulation of distinct markers directed to neuronal preser-
vation. These signalosomes may become activated upon associa-
tion with a variety of stimuli, leading to the initiation of different 
signal transduction events that may promote neuronal survival 
against different injuries. Although some of the components of 
these platforms are starting to be identified, the complete picture 
is surely more complex, involving alterations in different signaling 
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